Mark Bustoros
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Glioma Diagnosis and Treatment
Papers in
- Hematology 11
- Multiple Myeloma Research and Treatments 10
-
- Protein Degradation and Inhibitors 3
- Co-authors
- Irene M. Ghobrial (9 shared papers)Alexandre Detappe (3 shared papers)Tarek H. Mouhieddine (3 shared papers)Salomon Manier (3 shared papers)Yu J. Shen (1 shared paper)Christoph Schliemann (1 shared paper)Oliver Lomas (1 shared paper)Carl Jannes Neuse (1 shared paper)
- Journals
- Blood (3 papers)American Society of Clinical Oncology Educational Book (2 papers)Journal of Clinical Oncology (2 papers)Hematology/Oncology Clinics of North America (1 paper)HemaSphere (1 paper)
- Partner nations
- United StatesFranceGermany
In The Last Decade
Mark Bustoros
20 papers receiving 306 citations
Peers
Comparison fields: 5 of 51
- Hematology 118
- Genetics 69
- Cancer Research 42
- Oncology 68
- Obstetrics and Gynecology 17
Countries citing papers authored by Mark Bustoros
This map shows the geographic impact of Mark Bustoros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Bustoros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Bustoros more than expected).
Fields of papers citing papers by Mark Bustoros
This network shows the impact of papers produced by Mark Bustoros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Bustoros. The network helps show where Mark Bustoros may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Bustoros, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 74 | |
| 2 | 2016 | 33 | |
| 3 | 2016 | 28 | |
| 4 | 2017 | 25 | |
| 5 | 2020 | 22 | |
| 6 | 2018 | 22 | |
| 7 | 2021 | 21 | |
| 8 | 2018 | 18 | |
| 9 | 2018 | 17 | |
| 10 | 2016 | 10 | |
| 11 | 2017 | 9 | |
| 12 | 2022 | 8 | |
| 13 | 2020 | 7 | |
| 14 | 2019 | 5 | |
| 15 | 2019 | 3 | |
| 16 | 2021 | 2 | |
| 17 | 2024 | 2 | |
| 18 | 2023 | 2 | |
| 19 | 2018 | 2 | |
| 20 | 2023 | 1 |
About Mark Bustoros
Mark Bustoros is a scholar working on Hematology, Molecular Biology, Genetics, Pathology and Forensic Medicine and Oncology, having authored 22 papers that have together received 311 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (10 papers), Protein Degradation and Inhibitors (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Cancer Mechanisms and Therapy (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Pregnancy and preeclampsia studies (2 papers) and CNS Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Hematology (118 citations), Genetics (69 citations), Cancer Research (42 citations), Oncology (68 citations) and Obstetrics and Gynecology (17 citations). Mark Bustoros has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Irene M. Ghobrial, Alexandre Detappe, Tarek H. Mouhieddine, Salomon Manier, Yu J. Shen, Christoph Schliemann, Oliver Lomas, Carl Jannes Neuse, Dimitris G. Placantonakis and P. Peter Ghoroghchian. Their work appears in journals such as Blood, American Society of Clinical Oncology Educational Book, Journal of Clinical Oncology, Hematology/Oncology Clinics of North America and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.